The Canadian-based psychedelics company Nirvana Life Sciences Inc. filed a patent for the deuterated form of 7-hydroxymitragynine (D7-h.), commonly known as Kratom. Nirvana focuses on developing mental health therapeutics including non-addictive chronic pain and relapse-preventing products. Recognition and use of Kratom, utilized in Southeast Asia for the past 150 years, has increased in Canada, the U.S. and worldwide

Read More